Skip to main content
. 2018 Jan 2;50(4):1252–1259. doi: 10.4143/crt.2017.438

Fig. 4.

Fig. 4.

Biomarker levels at baseline and after two cycles of dovitinib. (A) Fibroblast growth factor receptor 2 (FGFR2) levels. (B) Vascular endothelial growth factor receptor 2 (VEGFR2) levels.